Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Pesce

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|September 10, 2019
Different Features of Tumor-Associated NK Cells in Patients With Low-Grade or High-Grade Peritoneal CarcinomatosisSilvia Pesce, Valerio Belgrano, Marco Greppi, et al.
Cancers|December 1, 2020
Cancer Immunotherapy by Blocking Immune Checkpoints on Innate LymphocytesSilvia Pesce, Sara Trabanelli, Clara Di Vito, et al.
Frontiers in Immunology|September 8, 2023
The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancersChiara M Biatta, Michele Paudice, Marco Greppi, et al.
Immunology Letters|September 20, 2024
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advancesMarco Greppi, Fabiana De Franco, Valentina Obino, et al.
Frontiers in Immunology|July 24, 2023
A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humansFederico Rebaudi, Alfredo De Rosa, Marco Greppi, et al.
Cancer Treatment Reviews|September 29, 2024
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancerFederico Rebaudi, Fabiana De Franco, Rayan Goda, et al.
Cell Death Discovery|March 28, 2026
Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancerSimone Ielpo, Francesca Barberini, Alice Gaiba, et al.
Frontiers in Immunology|July 3, 2025
Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1<sup>+</sup> NK cells in microsatellite instability tumorsValentina Obino, Chiara Giordano, Simona Carlomagno, et al.
Cancer Immunology Research|April 4, 2019
Accumulation of Circulating CCR7<sup>+</sup> Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic PathwayCostanza Maria Cristiani, Alice Turdo, Valeria Ventura, et al.
Frontiers in Immunology|November 22, 2021
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK CellsFabio Guolo, Paola Minetto, Silvia Pesce, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|September 10, 2019
Different Features of Tumor-Associated NK Cells in Patients With Low-Grade or High-Grade Peritoneal CarcinomatosisSilvia Pesce, Valerio Belgrano, Marco Greppi, et al.
Cancers|December 1, 2020
Cancer Immunotherapy by Blocking Immune Checkpoints on Innate LymphocytesSilvia Pesce, Sara Trabanelli, Clara Di Vito, et al.
Frontiers in Immunology|September 8, 2023
The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancersChiara M Biatta, Michele Paudice, Marco Greppi, et al.
Immunology Letters|September 20, 2024
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advancesMarco Greppi, Fabiana De Franco, Valentina Obino, et al.
Frontiers in Immunology|July 24, 2023
A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humansFederico Rebaudi, Alfredo De Rosa, Marco Greppi, et al.
Cancer Treatment Reviews|September 29, 2024
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancerFederico Rebaudi, Fabiana De Franco, Rayan Goda, et al.
Cell Death Discovery|March 28, 2026
Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancerSimone Ielpo, Francesca Barberini, Alice Gaiba, et al.
Frontiers in Immunology|July 3, 2025
Colorectal cancer-infiltrating NK cell landscape analysis unravels tissue-resident PD-1<sup>+</sup> NK cells in microsatellite instability tumorsValentina Obino, Chiara Giordano, Simona Carlomagno, et al.
Cancer Immunology Research|April 4, 2019
Accumulation of Circulating CCR7<sup>+</sup> Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic PathwayCostanza Maria Cristiani, Alice Turdo, Valeria Ventura, et al.
Frontiers in Immunology|November 22, 2021
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK CellsFabio Guolo, Paola Minetto, Silvia Pesce, et al.
Pageof 6